Heart rate reduction in cardiovascular disease and therapy (Q37784463)

23 August 2017

title

Heart rate reduction in cardiovascular disease and therapy (English)

1 reference

23 August 2017

main subject

cardiovascular disease

1 reference

7

Luigi Tavazzi

1 reference

23 August 2017

4

Michel Komajda

1 reference

23 August 2017

3

Karl Swedberg

1 reference

23 August 2017

8

Ulrich Laufs

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20809390

4 July 2024

author name string

Jan-Christian Reil

1

1 reference

23 August 2017

Florian Custodis

2

1 reference

23 August 2017

Ian Ford

6

1 reference

23 August 2017

Michael Böhm

9

1 reference

23 August 2017

Jeffrey S. Borer

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20809390

4 July 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20809390

4 July 2024

publication date

1 September 2010

1 reference

Clinical Research in Cardiology

23 August 2017

published in

1 reference

23 August 2017

volume

100

1 reference

23 August 2017

issue

1

1 reference

23 August 2017

page(s)

11-19

1 reference

Heart rate in the pathophysiology of coronary blood flow and myocardial ischaemia: benefit from selective bradycardic agents

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00392-010-0207-X

The role of heart rate in the development of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-010-0207-X

Heart rate and cardiovascular mortality: the Framingham Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-010-0207-X

Resting heart rate in cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-010-0207-X

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-010-0207-X

Elevated heart rate: a "new" cardiovascular risk factor?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-010-0207-X

Influence of heart rate on mortality after acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-010-0207-X

Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-010-0207-X

Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-010-0207-X

Albuminuria reflects widespread vascular damage. The Steno hypothesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-010-0207-X

Association of heart rate with microalbuminuria in cardiovascular risk patients: data from I-SEARCH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-010-0207-X

Atrial fibrillation and heart rate independently correlate to microalbuminuria in hypertensive patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-010-0207-X

Heart rate reduction by ivabradine reduces oxidative stress, improves endothelial function, and prevents atherosclerosis in apolipoprotein E-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-010-0207-X

Chronic heart rate reduction by ivabradine prevents endothelial dysfunction in dyslipidaemic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-010-0207-X

Behaviorally elicited heart rate reactivity and atherosclerosis in ovariectomized cynomolgus monkeys (Macaca fascicularis).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-010-0207-X

Minimum heart rate and coronary atherosclerosis: independent relations to global severity and rate of progression of angiographic lesions in men with myocardial infarction at a young age

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-010-0207-X

Left ventricular muscle mass and elevated heart rate are associated with coronary plaque disruption.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-010-0207-X

Relationship Between the Dynamic Geometry and Wall Thickness of a Human Coronary Artery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-010-0207-X

Hemodynamic factors and atheromatic plaque rupture in the coronary arteries: from vulnerable plaque to vulnerable coronary segment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-010-0207-X

Structure-dependent dynamic mechanical behavior of fibrous caps from human atherosclerotic plaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-010-0207-X

Quantitative relationship between resting heart rate reduction and magnitude of clinical benefits in post-myocardial infarction: a meta-regression of randomized clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-010-0207-X

Beta-blockers and sudden cardiac death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-010-0207-X

Effects of beta blockade on sudden cardiac death during acute myocardial infarction and the postinfarction period

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-010-0207-X

Efficacy of the I(f) current inhibitor ivabradine in patients with chronic stable angina receiving beta-blocker therapy: a 4-month, randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-010-0207-X

Heart rate reduction by I(f)-channel inhibition and its potential role in heart failure with reduced and preserved ejection fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-010-0207-X

Heart rate lowering by specific and selective I(f) current inhibition with ivabradine: a new therapeutic perspective in cardiovascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-010-0207-X

Heart rate and cardiac rhythm relationships with bisoprolol benefit in chronic heart failure in CIBIS II Trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-010-0207-X

What resting heart rate should one aim for when treating patients with heart failure with a beta-blocker? Experiences from the Metoprolol Controlled Release/Extended Release Randomized Intervention Trial in Chronic Heart Failure (MERIT-HF).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-010-0207-X

Influence of heart rate, blood pressure, and beta-blocker dose on outcome and the differences in outcome between carvedilol and metoprolol tartrate in patients with chronic heart failure: results from the COMET trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-010-0207-X

Trends in prevalence and outcome of heart failure with preserved ejection fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-010-0207-X

Heart failure with normal left ventricular ejection fraction: what is the evidence?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-010-0207-X

Effect of ivabradine in dobutamine induced sinus tachycardia in a case of acute heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-010-0207-X

Favourable effects of heart rate reduction with intravenous administration of ivabradine in patients with advanced heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-010-0207-X

Circumferential stress and matrix metalloproteinase 1 in human coronary atherosclerosis. Implications for plaque rupture

21 January 2018

1 reference

12 December 2020

Combined ventricular systolic and arterial stiffening in patients with heart failure and preserved ejection fraction: implications for systolic and diastolic reserve limitations

1 reference

12 December 2020

Microalbuminuria is associated with impaired brachial artery, flow-mediated vasodilation in elderly individuals without and with diabetes: further evidence for a link between microalbuminuria and endothelial dysfunction--the Hoorn Study

1 reference

12 December 2020

The influence of heart rate on coronary artery atherosclerosis

1 reference

12 December 2020

Long-term prognostic value of resting heart rate in patients with suspected or proven coronary artery disease

1 reference

12 December 2020

Effect of verapamil on mortality and major events after acute myocardial infarction (the Danish Verapamil Infarction Trial II--DAVIT II)

1 reference

12 December 2020

Meta-analysis: beta-blocker dose, heart rate reduction, and death in patients with heart failure

1 reference

12 December 2020

Retarding effect of lowered heart rate on coronary atherosclerosis

1 reference

12 December 2020

Heart rate correlates with severity of coronary atherosclerosis in young postinfarction patients

1 reference

12 December 2020

Commentary to the article: Swedberg K, Komajda M, Böhm M et al. Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study. Lancet, 2010; DOI:10.1016/S01406736(10)61198-1

1 reference

12 December 2020

European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice ...

1 reference

12 December 2020

Microalbuminuria and endothelial dysfunction in essential hypertension

1 reference

12 December 2020

Ivabradine in combination with beta-blocker therapy for the treatment of stable angina pectoris in every day clinical practice

1 reference

12 December 2020

Heart rate reduction with ivabradine improves erectile dysfunction in parallel to decrease in atherosclerotic plaque load in ApoE-knockout mice

1 reference

12 December 2020

Experimental atherosclerosis at the carotid bifurcation of the cynomolgus monkey. Localization, compensatory enlargement, and the sparing effect of lowered heart rate

1 reference

12 December 2020

A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results

1 reference

12 December 2020

Cyclic Bending Contributes to High Stress in a Human Coronary Atherosclerotic Plaque and Rupture Risk: In Vitro Experimental Modeling and Ex Vivo MRI-Based Computational Modeling Approach.

1 reference

12 December 2020

Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial

1 reference

12 December 2020

Strain-dependent vascular remodeling: the "Glagov phenomenon" is genetically determined

1 reference

12 December 2020

10.1007/S00392-010-0207-X

Identifiers

DOI

1 reference

23 August 2017

1 reference